drugset / Trial / NCT00814528
Photodynamic Therapy Mediated by Topical Application of 5- ALA for the Treatment of Actinic Keratoses
Withdrawn
University of Chicago
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to compare the treatment of skin growths called actinic keratoses (AK) with 5-ALA PDT, an FDA-approved treatment, versus treatment with other conventionally used FDA-approved agents such as cryotherapy, Imiquimod, or 5-fluorouracil (5-FU).
Timeline
- Start
- 2007-11
- Primary completion
- 2009-09
- Completion
- 2009-09
Outcome
Outcome not reported
Stopped: “The study never started due to the Principal Investigator leaving the institution”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aminolevulinic Acid | Diagnostic / imaging agent | 20 % | Topical |
| Subject | Imiquimod | Other / unclassified | — | Topical |
| Subject | fluorouracil | Small molecule | — | Topical |